Bio Medica Laboratories SME IPO

Bio Medica Laboratories SME

Bio Medica Laboratories Limited, incorporated in 2015, is an Indian pharmaceutical manufacturer specializing in parenteral formulations. The company develops and contract-manufactures a wide range of ethical drugs, generic medicines, and over-the-counter (OTC) products in the form of liquid and dry powder injectables. Operating entirely on a B2B contract manufacturing model, it designs multi-dose and single-dose injectables for both human and veterinary applications. The company runs two specialized production facilities in Indore, Madhya Pradesh, certified for Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP).

Issue Price
139
Current GMP
₹-9 (-6.47%)
Overall Subscription
2.31x
Issue Size
₹52.43 Cr
Advertisement

Live Subscription by Application

CategoryApplications OfferedApplications ReceivedSubscription
QIB3660.17x
FII
-6-
DFI
-0-
MF
-0-
Other
-0-
NII5854570.78x
bNII
390350.09x
Corporate
-1-
Individual
-32-
Other
-2-
sNII
1954222.16x
Corporate
-2-
Individual
-406-
Other
-14-
IND8962,6142.92x
Total1,5173,0772.03x

Live Subscription by Shares

CategoryShares OfferedShares AppliedSubscription
QIB36.00K5.74 L15.94x
FII
-5.74 L-
DFI
-0-
MF
-0-
Other
-0-
NII17.55 L24.75 L1.41x
bNII
11.70 L11.93 L1.02x
Corporate
-1.89 L-
Individual
-8.96 L-
Other
-1.08 L-
sNII
5.85 L12.82 L2.19x
Corporate
-6.00K-
Individual
-12.34 L-
Other
-42.00K-
IND17.92 L52.28 L2.92x
Total35.83 L82.77 L2.31x

Subscription Summary

QIB
Shares Applied:15.94x
Applications Offered:0.17x
NII
Shares Applied:1.41x
Applications Offered:0.78x
IND
Shares Applied:2.92x
Applications Offered:2.92x

Quick Stats

Total Categories3
IPO TypeSME
StatusAllotment Out

Get IPOwiz App

Track IPOs on the go with our mobile app

Download Now

Join us on Telegram for instant IPO updates!

Join Now

Data Last Updated

26 May 2026, 12:28 pm

Auto-refreshing
Advertisement

Understanding Subscription Categories

QIB

Qualified Institutional Buyers

Includes FII, DFI, Mutual Funds, and other qualified institutions.

NII

Non-Institutional Investors

High net-worth individuals: bNII (₹10L+) and sNII (₹2L-₹10L).

IND

Individual Investors

Individual investors in SME IPOs up to ₹2 lakh.

Frequently Asked Questions

What is the current subscription status of Bio Medica Laboratories SME?
The current overall subscription for Bio Medica Laboratories SME is 2.31x. This indicates the total demand relative to the shares offered. Higher subscription typically suggests strong investor interest.
How to check Bio Medica Laboratories SME subscription status?
You can check Bio Medica Laboratories SME subscription status on IPOwiz, BSE website, NSE website, or your broker's platform. Subscription data is updated regularly during the IPO period from 21 May 2026 to 25 May 2026.
What do subscription numbers mean?
Subscription numbers show how many times the IPO is oversubscribed. For example, 2.31x means the IPO received 2.31x times more applications than shares available. Higher subscription in retail category generally means lower allotment chances.
When does Bio Medica Laboratories SME subscription close?
The subscription for Bio Medica Laboratories SME closes on 25 May 2026. Applications must be submitted before the closing time on this date. Late applications will not be accepted.
What is the difference between QIB, NII, and Individual (IND) subscription?
QIB (Qualified Institutional Buyers) includes mutual funds, FIIs, and other institutions. NII (Non-Institutional Investors) includes high net-worth individuals investing above ₹2 lakh. Individual (IND) includes individual investors with applications up to ₹2 lakh. Each category has separate subscription quotas.
How does subscription affect allotment chances?
Higher subscription in your category means lower allotment chances. For example, if retail subscription is 2.31x, it means there are 2.31x times more applications than shares available, making allotment competitive.
When will Bio Medica Laboratories SME allotment be finalized?
The allotment for Bio Medica Laboratories SME will be finalized and announced on 26 May 2026. You can check your allotment status on the registrar's website, BSE, NSE, or your demat account after this date.
What happens after subscription closes?
After subscription closes on 25 May 2026, the company and registrar process all applications. Allotment is finalized by 26 May 2026, and shares are credited to successful applicants' demat accounts before the listing date on 29 May 2026.
Can I apply after subscription closes?
No, you cannot apply after the subscription closes on 25 May 2026. All IPO applications must be submitted during the subscription period from 21 May 2026 to 25 May 2026. Late applications are automatically rejected.
What is the issue size and lot size for Bio Medica Laboratories SME?
The issue size for Bio Medica Laboratories SME is ₹52.43 Cr, and the lot size is 1000 shares. The price range is ₹132.0 - ₹139.0. You must apply in multiples of the lot size.